What is Pilocarpine Market?
Pilocarpine is a class of medications called cholinergic agonists used to treat dry mouth caused by radiotherapy in people with head and neck cancer and to treat dry mouth in people due to a certain immune disease such as Sjogren's syndrome (a condition that affects the immune system and causes dryness of certain parts of the body such as the eyes and mouth). This medication stimulates certain nerves that increase the amount of saliva production making it easier and more comfortable to speak and swallow. The factors such as Increased Prevalence of Sjogren's syndrome causing Dry Mouth and Increased Number of Patients taking Radiation Therapy in Head and Neck Cancer are the key drivers for the global pilocarpine market.
The market study is being classified by Type (Pilocarpine Tablets and Pilocarpine Eye Drops), by Application (Dry Mouth and Gluacom or Ocular Hypertension) and major geographies with country level break-up.
Actavis (United States), Medline Industries, Inc. (United States), LGM Pharma (United States), Kissei Pharmaceutical (Japan), Santen Oy (Finland), Aurobindo Pharma Limited (India), Akorn Inc. (United States), Lannett Co Inc (United States), Novartis International AG (Switzerland) and Sandoz (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Somerset Therapeutics LLC (United States) and Norgine B.V. (Netherlands).
There are various companies that are operating in the new geographical regions by adopting various market growth initiatives such as mergers & acquisitions, expansions, investments, and others. The new players are entering the market to capture market growth opportunities. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pilocarpine market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Pilocarpine market by Type, Application and Region.
On the basis of geography, the market of Pilocarpine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Sjogren's syndrome causing Dry Mouth
- Increased Number of Patients taking Radiation Therapy in Head and Neck Cancer
- Advancements in the Medical Science
- Robust Increase in the Distribution Channels
- Side Effects of the Pilocarpine such as Shortness of Breath, Severe Headache, and Slow Heart Rate
- Growth in the Healthcare Industry Worldwide
- Development of Healthcare Infrastructure in Emerging Economies
- Stringent Government Rules and Regulations
In January 2020, Medline Canada has acquired Médi-Sélect for an all-cash transaction for an undisclosed amount. Médi-Sélect will stay as an independent division of Medline Canada throughout the rest of the year.
Key Target AudiencePilocarpine Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase